First Eagle Investment Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q2 2014. The put-call ratio across all filers is 13.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2017$100,000
-38.3%
50,0000.0%0.00%
Q3 2017$162,000
+153.1%
50,000
+150.0%
0.00%
Q2 2017$64,000
+12.3%
20,0000.0%0.00%
Q1 2017$57,000
+21.3%
20,0000.0%0.00%
Q4 2016$47,000
+38.2%
20,0000.0%0.00%
Q3 2016$34,000
+61.9%
20,0000.0%0.00%
Q2 2016$21,000
+23.5%
20,0000.0%0.00%
Q1 2016$17,000
-29.2%
20,0000.0%0.00%
Q4 2015$24,000
-29.4%
20,0000.0%0.00%
Q3 2015$34,000
-19.0%
20,0000.0%0.00%
Q2 2015$42,000
-22.2%
20,0000.0%0.00%
Q1 2015$54,000
+5.9%
20,0000.0%0.00%
Q4 2014$51,000
+37.8%
20,0000.0%0.00%
Q3 2014$37,000
-30.2%
20,0000.0%0.00%
Q2 2014$53,000
-24.3%
20,0000.0%0.00%
Q1 2014$70,000
-22.2%
20,0000.0%0.00%
Q4 2013$90,000
+11.1%
20,0000.0%0.00%
Q3 2013$81,000
-2.4%
20,0000.0%0.00%
Q2 2013$83,00020,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2014
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders